Pharmala Biotech Holdings Inc.
Pharmala Biotech Holdings Inc.
Pharmala is focused on manufacture of Active Pharmaceutical Ingredients, of the Substituted methylenedioxy- phenethylamines class (“MDXX”), including 3,4-Methylenedioxymethamphetamine (“MDMA”). Pharmala also intends to undertake development of novel formulations of MDMA and the MDXX class of compounds, as well as developing novel drug delivery pathways for these molecules.
Pharmala Biotech Holdings Inc. (MDMA)
Pharmala Biotech Holdings Inc. (MDMA)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
---|---|---|---|---|---|
CIBC World Markets Inc. | 7,000 | 0.165 | 0.17 | 11,000 | TD Securities Inc. |
Virtu Canada Corp. | 500 | 0.16 | 0.17 | 500 | Virtu Canada Corp. |
CIBC World Markets Inc. | 9,000 | 0.16 | 0.175 | 3,000 | BMO Nesbitt Burns Inc. |
National Bank Financial Inc. | 500 | 0.155 | 0.175 | 2,000 | TD Securities Inc. |
TD Securities Inc. | 11,000 | 0.155 | 0.175 | 1,000 | CIBC World Markets Inc. |
CIBC World Markets Inc. | 2,500 | 0.155 | 0.185 | 6,000 | BMO Nesbitt Burns Inc. |
CIBC World Markets Inc. | 1,000 | 0.155 | 0.19 | 5,000 | BMO Nesbitt Burns Inc. |
National Bank Financial Inc. | 12,000 | 0.15 | 0.19 | 25,000 | TD Securities Inc. |
Questrade Inc. | 500 | 0.15 | 0.19 | 5,000 | BMO Nesbitt Burns Inc. |
National Bank Financial Inc. | 2,000 | 0.15 | 0.19 | 94,000 | National Bank Financial Inc. |
Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
---|---|---|---|---|---|
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
---|---|---|---|---|---|
1 | 7,000 | 0.165 | 0.17 | 11,500 | 2 |
2 | 9,500 | 0.16 | 0.175 | 6,000 | 3 |
4 | 15,000 | 0.155 | 0.185 | 6,000 | 1 |
7 | 60,500 | 0.15 | 0.19 | 130,000 | 5 |
2 | 12,000 | 0.145 | 0.195 | 5,000 | 1 |
Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
---|---|---|---|---|---|
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
---|---|---|---|---|---|---|
Apr 2, 14:41 | 0.165 | 0.005 | 20,000 | CIBC World Markets Inc. | Anonymous | CSE |
Apr 2, 14:41 | 0.165 | 0.005 | 40,000 | CIBC World Markets Inc. | National Bank Financial Inc. | CSE |
Apr 2, 14:38 | 0.165 | 0.005 | 5,000 | CIBC World Markets Inc. | Scotia Capital Inc. | CSE |
Apr 2, 14:38 | 0.165 | 0.005 | 500 | CIBC World Markets Inc. | Virtu Canada Corp. | CSE |
Apr 2, 13:43 | 0.155 | -0.005 | 500 | Anonymous | Virtu Canada Corp. | CSE |
Company Info
SEDAR Information
Company Info
Capitalization
Company Officers
Bulletins
2022-0110 - New Listing - Pharmala Biotech Holdings Inc. (MDMA)
le 10 janvier/January 2022
The common shares of Pharmala Biotech Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.